RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
VKSIX
Price
$20.71
Change
-$0.22 (-1.05%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs VKSIX

Header iconRPTIX vs VKSIX Comparison
Open Charts RPTIX vs VKSIXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Virtus KAR Small-Mid Cap Core I
Price$20.71
Change-$0.22 (-1.05%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs VKSIX Comparison Chart
Loading...
VS
RPTIX vs. VKSIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and VKSIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. VKSIX (2.19B). RPTIX pays higher dividends than VKSIX: RPTIX (0.18) vs VKSIX (0.00). RPTIX was incepted earlier than VKSIX: RPTIX (9 years) vs VKSIX (7 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. VKSIX (18.00). VKSIX has a lower initial minimum investment than RPTIX: VKSIX (100000) vs RPTIX (500000). VKSIX annual gain was more profitable for investors over the last year : 24.83 vs. RPTIX (14.81). VKSIX return over 5 years is better than : 78.55 vs. RPTIX (15.09).
RPTIXVKSIXRPTIX / VKSIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years7 years-
Gain YTD9.12710.80884%
Front LoadN/AN/A-
Min. Initial Investment500000100000500%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B2.19B1,434%
Annual Yield % from dividends0.180.00-
Returns for 1 year14.8124.8360%
Returns for 3 years-13.577.98-170%
Returns for 5 years15.0978.5519%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp